# OnCo record paper-esgo-estro-esp-endometrial-concin-ijgc-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-esgo-estro-esp-endometrial-concin-ijgc-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-esgo-estro-esp-endometrial-concin-ijgc-2021" ;
  schema:name "ESGO/ESTRO/ESP guidelines for the management of endometrial carcinoma (2021)"@en ;
  schema:description "The European gynaecological oncology, radiotherapy and pathology societies' joint guideline integrates molecular classification into risk groups for endometrial cancer and sets adjuvant treatment for each, including no adjuvant therapy for early POLE-mutated tumours."@en ;
  schema:url <https://onco.cc/key-papers/paper-esgo-estro-esp-endometrial-concin-ijgc-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1136/ijgc-2020-002230>, <https://pubmed.ncbi.nlm.nih.gov/33397713/> ;
  schema:sameAs <https://doi.org/10.1136/ijgc-2020-002230> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Concin N, Matias-Guiu X, Vergote I, et al." ;
  onco:cancers <https://onco.cc/cancers/endometrial-nsmp/>, <https://onco.cc/cancers/endometrial-pole-ultramutated/> ;
  onco:journals <https://onco.cc/journals/international-journal-of-gynecological-cancer/> .